EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS162-00420 
Organism
Homo sapiens 
Tissue/cell
Plasma_cell_myeloma 
Coordinate
chr1:93418440-93419970 
TF binding sites/motifs
Number: 4             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
IRF1MA0050.2chr1:93419248-93419269TAATGGAAACAGAAAGCAGAA-6.33
IRF1MA0050.2chr1:93419917-93419938CTTTTCTTTCTTTTTTTTTTT+6.41
IRF1MA0050.2chr1:93419476-93419497AAACAAAAAATGAAACAGAAA-6.84
MEF2CMA0497.1chr1:93418918-93418933AAATTAAAAATAGAA+6.12
Number of super-enhancer constituents: 8             
IDCoordinateTissue/cell
SE_10454chr1:93414970-93419433CD19_Primary
SE_11145chr1:93406552-93419838CD20
SE_25753chr1:93416260-93419737DND41
SE_39663chr1:93415190-93419245Jurkat
SE_59074chr1:93416515-93460130Ly3
SE_60696chr1:93409947-93446596DHL6
SE_61077chr1:93411217-93460121HBL1
SE_62582chr1:93394336-93457589Tonsil
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr19341900093419800
Number: 1             
IDChromosomeStartEnd
GH01I092949chr19341514093419717
Enhancer Sequence
AAAACTTGTG GCACTAGCTC TAAGATCTAA TAATAGTCTA TGACTCTGAT ACTATGCTAC 60
ATCTGAAATG GATGTACTAA TTCAGAAGCT TGTTAATACA TTAAAATCTC TCTTGGAAGA 120
ATATCTTCAA ACATGTTTAC CCTGTTCTTA AGAAAGGGGA ACTCTGCTCA CAATAACACA 180
TAACCCTGTT GAATAAATAT CAATCTGAAA CAACAAATCA AGAAGGAACT TTCTCCAAAG 240
AAGATATACA AATGGCCAAA AAGCATATGA AAAGATGTTC AACACCACTA ATCATCAGGA 300
AAGTGAATAA AAACTAAAAC AAGGTATCAG CTCACGCCCG TGAGAATGGT CACTCTTAAA 360
AAAAAAAAAA GAAAAGAAGT GCAGACGGGG ATGTGGAAAA ATTGAAACCC TTGTGTATTG 420
TTGGTGGGAA TGTAAAAGGG TAAAGCCACT TTGGAAAACA GTATGAAGGT TGCTAAAAAA 480
ATTAAAAATA GAATTACCAT GTGATCCAAC AATCCCACTT CTGGATATAC AAAAAAATTG 540
AAAGCAAGAT CTCAAAGAGA TATTTGCACT CCCATGTTCA TTGTAGTACA ATTCACAATA 600
GCCAAGAGGT AGAGGCAACC TAAATGTTCA TCGACTAATG AATGGATAAA GGAAATGTGG 660
AATATACATA CAATGGAATA CTATTCACCT TTAAAAAAGA AGGAAATCCT GTCATAATCT 720
ACATGGGTGA CATTATGTTA AGTGAAATAA GGCAGTCACA AAAAGACAAA TGCTGTGTGA 780
TTCCACTTAT ATGAAGTATA AAGCAGTCTA ATGGAAACAG AAAGCAGAAT GTGGTCACCA 840
AGGGCCAGGG GCAGGAGGAA ATGAGGAGTC GTTCAATGGG TAGAGTTTCG ACTTTGCAGG 900
ATGAAGAAGT TCTAGAGATC TGCTGCACAG ATCTTTGTTG CTGCACAAAG TGCATAAAAT 960
AGTTAATACT ACTATACTAT ATGCTTAAAA ATGGTTAAGA TAGCAAATTT TATGTGCTTT 1020
TGACCATAAT TTAAAAAAAC AAAAAATGAA ACAGAAAAAA ATAACCACCA TTCCATGATC 1080
ACACCTAAGA AAGATAACTA TTTAATTTCA TTAAATACCC AATCAACAAC AAAAAAGGAA 1140
TTGCTTATTT TCAAAGATAA ATTCATTTAC TAATATTTTG GGTTATTAAA ACATGCACAT 1200
TGCAATATCC TGGTTTTCTA AACTCGCATA CTTCGTAGAT TAAAAAGTTT TAAAGGAAAA 1260
TTATTTGCAA ATGATTTGAA CATCTAGAAA TGAATATGGC CAGACATAGT AGCTCATACA 1320
TATAATCCTA GCATTTTGGA AGTCCAAGGT GGGAAGGTGC ACTTGAACCC AGGAGTTTGA 1380
GACCAGCCTG GGCAACAAAG CAAGACCCTG TCTCACAAAA AAAAAAATAA ATAAATAAAT 1440
AAAAGAAATG GATATGTTAA AAATATTAAC ACTTTATCTT TTCTTTCTTT TTTTTTTTTT 1500
TTTTTTTGTT TTGAGACAGA GTCTCACTCT 1530